| 项目编号 | PRJCA005206 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 项目标题 | Dynamic recurreAgriculturalnce risk and adjuvant chemotherapy benefit prediction by Circulating tumor DNA in resected non-small cell lung cancer | ||||||||
| 涉及领域 | Medical | ||||||||
| 数据类型 |
Targeted Locus (Loci)
Raw sequence reads Genome sequencing |
||||||||
| 物种名称 | Homo sapiens | ||||||||
| 描述信息 | In this study, we sought to evaluate the utility of ultradeep targeted next-generation sequencing (NGS) on serial longitudinal ctDNA sampling post-surgery in resected NSCLC patients for MRD detection and ACT treatment decision-making, and dynamic risk prediction of recurrence during post-surgical and post-ACT disease surveillance. | ||||||||
| 样品范围 | Multiisolate | ||||||||
| 发布日期 | 2021-05-20 | ||||||||
| 项目资金来源 |
|
||||||||
| 提交者 | GUO WEI (guowei@cicams.ac.cn) | ||||||||
| 提交单位 | National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College | ||||||||
| 提交日期 | 2021-03-17 |
| 资源名称 | 描述 |
|---|---|
| BioSample (568) show | - |